The Global Infant Incubator Market size is expected to reach $944.9 million by 2030, rising at a market growth of 6.8% CAGR during the forecast period. In the year 2022, the market attained a volume of 321.9 thousand units, experiencing a growth of 7.0% (2019-2022).
Technological advancements extend to transport incubators, facilitating the safe transportation of newborns between hospital departments or healthcare facilities. Thus, the Transport Incubator segment acquired $1,60,895.7 thousand in 2022. These innovations include shock absorption systems, advanced monitoring during transit, and improved power management. Technological improvements often include user-friendly interfaces for healthcare professionals. Touchscreen displays, intuitive controls, and automated features enhance infant incubators' ease of use and efficiency. The continuous evolution of technology in neonatal care devices, including infant incubators, contributes significantly to the expansion of the market. Some of the factors impacting the market are the increase in birth rate of premature infants, surge in awareness regarding neonatal care, and high cost of infant incubators.
The global incidence of premature births has been on the rise, influenced by factors such as maternal age, multiple pregnancies (twins, triplets, etc.), lifestyle choices, and underlying health conditions. Premature infants, especially those born very early, often face health challenges due to underdeveloped organs and systems. They may have difficulty regulating body temperature, breathing, and feeding. It provides a controlled and supportive environment that helps address these vulnerabilities. It becomes essential to create a warm and controlled environment, preventing hypothermia and providing optimal conditions for the infant's growth and development. Additionally, Heightened awareness educates healthcare providers and parents about maintaining a controlled environment for newborns, especially premature infants. It creates a stable and regulated space that supports the unique needs of neonates, including temperature control and respiratory support. Knowledgeable healthcare providers and parents are more likely to recognize the signs of hypothermia in newborns and understand the role of incubators in preventing this condition. Expectant parents gain knowledge about the potential challenges faced by premature infants and the importance of having access to neonatal care facilities equipped with advanced technologies like incubators. The surge in awareness regarding neonatal care is a multifaceted driver that positively impacts the market.
However, the initial purchase cost of infant incubators can impose a considerable financial strain on healthcare institutions, especially those with limited budgets. This may affect the ability of smaller hospitals, clinics, or facilities in resource-constrained settings to invest in sufficient quantities of infant incubators. The high cost can impact the development and maintenance of neonatal care infrastructure. This includes establishing neonatal intensive care units (NICUs) and procuring other essential equipment, such as monitoring devices and respiratory support systems. The high cost can indirectly impact patient outcomes if healthcare facilities cannot provide the necessary equipment and resources for effective neonatal care. The above factors will hamper market growth in the coming years.
On the basis of product, the market is segmented into normal incubators, transport incubators, and hybrid incubators. In 2022, the normal incubator segment dominated the market. Incubators are designed to minimize the risk of contamination. They often include features like HEPA filters, air circulation systems, and easy-to-clean surfaces to maintain a sterile environment. Incubators play a crucial role in biotechnological and pharmaceutical research, supporting the growth of cells to produce proteins, vaccines, and other bio-based products. Normal incubators serve diverse purposes across scientific, medical, and industrial domains. They provide a controlled and stable environment to support the growth and development of living organisms or biological specimens for research, production, or healthcare purposes.
Based on application, the market is fragmented into neonatal hypothermia & low birth weight, jaundice, and others. The jaundice segment garnered a significant revenue share in the market in 2022. It is used for jaundice to incorporate a specialized light source, typically blue or white light, that emits a specific wavelength. The incubator allows controlled exposure of the infant's skin to the phototherapy light. This ensures the baby receives the necessary light to reduce bilirubin levels without causing harm. Incubators used for jaundice often use monitoring systems to track the baby's vital signs, including temperature, heart rate, and oxygen saturation. This allows healthcare providers to observe the baby's response to phototherapy closely.
By end user, the market is classified into neonatal & pediatric hospitals, maternity hospitals, and hospitals. In 2022, the neonatal & pediatric hospitals segment registered the highest revenue share in the market. Neonates, especially premature infants, struggle to regulate their body temperature. In the NICU, it maintains a controlled and stable temperature, creating a warm environment that helps prevent hypothermia. In these units, it can be used for newborns, especially those born prematurely or with complex medical conditions that require controlled environments. In both neonatal and pediatric hospitals, the use of infant incubators is tailored to the unique needs of newborns and young children, providing a supportive and controlled environment that is essential for their well-being and recovery.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 561.6 Million |
| Market size forecast in 2030 | USD 944.9 Million |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 6.8% from 2023 to 2030 |
| Number of Pages | 338 |
| Number of Table | 690 |
| Quantitative Data | Volume in Thousand Units, Revenue in USD million, and CAGR from 2019 to 2030 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product, Application, End User, Region |
| Country scope |
|
| Companies Included | GE HealthCare Technologies, Inc., Natus Medical Incorporated (Archimed SAS), Atom Medical Corporation, Phoenix Medical Systems Pvt. Ltd., Dragerwerk AG & Co. KGaA, Inspiration Healthcare Group PLC, Medicor Elektronika Zrt., Fanem Ltda., Koninklijke Philips N.V., Médipréma Group |
| Growth Drivers |
|
| Restraints |
|
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region generated the largest revenue share in the market. Several factors influence North America, including advancements in healthcare technology, well-established healthcare infrastructure, and a strong emphasis on neonatal care. A combination of advanced healthcare infrastructure, technological innovation, regulatory standards, financial resources, and a strong commitment to neonatal care drives the adoption of infant incubators in North America. These factors collectively contribute to the widespread use of infant incubators in the region's healthcare facilities.
Free Valuable Insights: Global Infant Incubator Market size to reach USD 944.9 Million by 2030
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Natus Medical Incorporated (Archimed SAS), Atom Medical Corporation, Phoenix Medical Systems Pvt. Ltd., Dragerwerk AG & Co. KGaA, Inspiration Healthcare Group PLC, Medicor Elektronika Zrt., Fanem Ltda., Koninklijke Philips N.V., Médipréma Group
By Product (Volume, Thousand Units, USD Million, 2019 to 2030)
By Application (Volume, Thousand Units, USD Million, 2019 to 2030)
By End User (Volume, Thousand Units, USD Million, 2019 to 2030)
By Geography (Volume, Thousand Units, USD Million, 2019 to 2030)
This Market size is expected to reach $944.9 million by 2030.
Increase in birth rate of premature infants are driving the Market in coming years, however, High cost of infant incubators restraints the growth of the Market.
GE HealthCare Technologies, Inc., Natus Medical Incorporated (Archimed SAS), Atom Medical Corporation, Phoenix Medical Systems Pvt. Ltd., Dragerwerk AG & Co. KGaA, Inspiration Healthcare Group PLC, Medicor Elektronika Zrt., Fanem Ltda., Koninklijke Philips N.V., Médipréma Group
In the year 2022, the market attained a volume of 321.9 thousand units, experiencing a growth of 7.0% (2019-2022).
The Neonatal hypothermia & low birth weight segment is leading the Market, by Application in 2022; thereby, achieving a market value of $586.2 Million by 2030.
The North America region dominated the Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $402.8 Million by 2030.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 